Inhalation Anesthesia Market share to reach $1.6bn by 2024
Get more details @ http://bit.ly/2eEa96c Some of the prominent players in inhalation anesthesia market are Baxter International, Hikma Pharmaceuticals, Mylan, Eisai, Halocarbon Products, Abbott, Piramal and Lunan Pharmaceutical.
Get more details @ http://bit.ly/2eEa96c
Some of the prominent players in inhalation anesthesia market are Baxter International, Hikma Pharmaceuticals, Mylan, Eisai, Halocarbon Products, Abbott, Piramal and Lunan Pharmaceutical.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
U.S. <strong>Inhalation</strong> <strong>Anesthesia</strong> <strong>Market</strong>, By Product, 2013 - <strong>2024</strong> (USD Million)<br />
Browse key industry insights spread across 126 pages with 148 tables & 8 market<br />
data figures & charts from the report <strong>Inhalation</strong> <strong>Anesthesia</strong> <strong>Market</strong> in detail along<br />
with the table of contents:<br />
https://www.gminsights.com/industry-analysis/inhalation-anesthesia-market<br />
Maintenance accounted for highest revenue <strong>share</strong> of the application segment in<br />
2016 and will grow at a significant rate over the forecast period owing <strong>to</strong> fac<strong>to</strong>rs like<br />
safety of airway as nearly all patients that are anesthetized <strong>by</strong> means of these<br />
products are intubated. Increasing use in patients with low oxygen carrying<br />
capacities such as the patients with respirational dysfunction or anemia will fuel the<br />
segment growth in the coming years.<br />
U.S. market was valued over USD 488 million in 2016 and will grow significantly over<br />
the coming years. Rising number of plastic surgeries and substantially increasing<br />
adoption rate of the process will drive the business growth in U.S. Furthermore,<br />
presence of associations that aids in maintaining the standards of anesthesiology will<br />
fuel the industry growth in the country.<br />
Germany accounted for highest revenue <strong>share</strong> in the region, owing <strong>to</strong> increasing<br />
chronic conditions associated with elderly population coupled with adoption rate of<br />
inhalation anesthesia. Growing prevalence of cancers and cardiovascular disorders<br />
accounting for approximately 66% of overall deaths in Germany will drive the<br />
industry growth over the forecast years.<br />
China will grow at a significant rate owing <strong>to</strong> its growing research studies in the<br />
business and high prevalence of lung cancer occurred due <strong>to</strong> pollution. Increasing<br />
use of sevoflurane and desflurane in general anesthesia pertaining <strong>to</strong> superiority of<br />
awakening afterwards surgical procedure as compared <strong>to</strong> traditional inhaled<br />
2 | P a g e
Change language